Taken together, the results showed that the i.c.m. administration of CLL preferentially depleted dural macrophages along dural sinuses, particularly LYVE-1+ and CD206+ macrophages that reside in proximity to MLVs, while having a limited impact on macrophages in the nonsinus area. The gene discussed is LYVE1; the disease is B-cell chronic lymphocytic leukemia.